Yu M, Takiguchi S, Takanishi D, Myers S, McNamara J J
Department of Surgery, University of Hawaii, Honolulu 96813, USA.
Crit Care Med. 1995 Apr;23(4):681-6. doi: 10.1097/00003246-199504000-00016.
To determine if treatment modalities (fluid, inotropes, and blood) would be altered based on preload measurements of right ventricular end-diastolic volume index measured by fast response thermodilution catheter, as compared with pulmonary artery occlusion pressure (PAOP).
A prospective clinical trial.
An 11-bed surgical intensive care unit (ICU) at The Queen's Medical Center, an affiliate of the University of Hawaii Surgical Residency program.
Surgical ICU patients who required pulmonary artery catheters, except those patients with arrhythmias or history of tricuspid valve disease.
During the first 48 hrs after catheter insertion, hemodynamic data were obtained at least every 4 hrs. Treatment of low preload was initiated only if clinical indications were present. These indications included a mean arterial pressure of < 70 mm Hg, heart rate of > 120 beats/min, urine output of < 40 mL/hr, stroke volume of < 40 mL/m2 with oxygen delivery of < 450 mL/min/m2, and lactic acidosis. Volume infusion was considered if PAOP was < 18 mm Hg and right ventricular end-diastolic volume index was < 140 mL/m2. Treatment was given tohigh preload, defined as a PAOP of > 18 mm Hg to prevent pulmonary edema. When PAOP and right ventricular end-diastolic volume index gave conflicting information, other clinical parameters were assessed to determine treatment.
Twenty-seven patients requiring 70 catheters were evaluated for the study. Thirteen patients with 46 pairs of data points completed the study. Fourteen patients were excluded from analysis due to irregular heart rate, poor quality of cardiac output at the time of volume infusion, or lack of major volume manipulation. PAOP and right ventricular end-diastolic volume index measurements agreed in 42 of 46 instances (PAOP of < 18 mm Hg, right ventricular end-diastolic volume index of < 140 mL/m2), leading to fluid treatment. In one instance, PAOP was > 18 mm Hg, right ventricular end-diastolic volume index was < 140 mL/m2, and the patient had normal blood pressure and good urine output. PAOP was used in this instance as a guide to diurese the patient, which led to improvement of heart rate and stroke volume index. Three measurements in two patients with high intra-abdominal pressure indicated a PAOP of > 18 mm Hg with right ventricular end-diastolic volume index of < 140 mL/m2. A rigid abdomen accompanied hypotension, tachycardia and low urine output. Thus, a fluid bolus was administered, resulting in improved blood pressure, stroke volume, and heart rate. PAOP were obtained at end-expiration. Positive end-expiratory pressure (PEEP) was removed for < 1 sec, if patients were on PEEP > or = 10 cm H2O, to avoid the effects of high intrapleural pressure on PAOP readings. Cardiac output was measured at end-expiration, and stroke volume index and right ventricular end diastolic volume index were derived.
In this small sample of surgical patients with sepsis, adult respiratory distress syndrome, and hemorrhagic shock (n = 13), the additional information derived from right ventricular end-diastolic volume index did not change treatment in 43 of 46 instances. However, patients with increased intra-abdominal pressures may show misleadingly high PAOP despite low preload. These patients clearly benefitted from the additional information derived from ventricular volume measurements. Additionally, clinicians who are reluctant to take off-PEEP PAOP may also find this catheter useful.
与肺动脉闭塞压(PAOP)相比,确定基于快速响应热稀释导管测量的右心室舒张末期容积指数的前负荷测量值是否会改变治疗方式(液体、血管活性药物和血液)。
一项前瞻性临床试验。
夏威夷大学外科住院医师项目附属的女王医疗中心的一个拥有11张床位的外科重症监护病房(ICU)。
需要肺动脉导管的外科ICU患者,但心律失常或有三尖瓣疾病史的患者除外。
在插入导管后的最初48小时内,至少每4小时获取一次血流动力学数据。仅当有临床指征时才开始低前负荷治疗。这些指征包括平均动脉压<70mmHg、心率>120次/分钟、尿量<40mL/小时、每平方米体表面积的每搏量<40mL且氧输送量<450mL/分钟/平方米以及乳酸酸中毒。如果PAOP<18mmHg且右心室舒张末期容积指数<140mL/平方米,则考虑进行容量输注。对于定义为PAOP>18mmHg的高前负荷进行治疗以预防肺水肿。当PAOP和右心室舒张末期容积指数给出相互矛盾的数据时,评估其他临床参数以确定治疗方案。
对27例需要70根导管的患者进行了研究评估。13例患者(46对数据点)完成了研究。14例患者因心率不齐、容量输注时心输出量质量差或缺乏大量容量操作而被排除在分析之外。在46例中的42例中,PAOP和右心室舒张末期容积指数测量结果一致(PAOP<18mmHg,右心室舒张末期容积指数<140mL/平方米),从而进行了液体治疗。在1例中,PAOP>18mmHg,右心室舒张末期容积指数<140mL/平方米,且患者血压正常、尿量良好。在此例中,以PAOP为指导对患者进行利尿治疗,这导致心率和每搏量指数得到改善。2例腹内压升高患者的3次测量显示PAOP>18mmHg且右心室舒张末期容积指数<140mL/平方米。坚硬的腹部伴有低血压、心动过速和少尿。因此,给予了液体冲击治疗,导致血压、每搏量和心率得到改善。在呼气末获取PAOP。如果患者使用呼气末正压(PEEP)≥10cmH₂O,则去除PEEP<1秒,以避免高胸膜腔内压对PAOP读数的影响。在呼气末测量心输出量,并得出每搏量指数和右心室舒张末期容积指数。
在这个患有脓毒症、成人呼吸窘迫综合征和失血性休克的外科患者小样本(n = 13)中,在46例中的43例中,从右心室舒张末期容积指数获得的额外信息并未改变治疗方案。然而,腹内压升高的患者尽管前负荷较低,但PAOP可能会出现误导性的升高。这些患者显然从心室容积测量获得的额外信息中受益。此外,那些不愿意在去除PEEP的情况下测量PAOP的临床医生可能也会发现这种导管很有用。